Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Moodys
Dow
Mallinckrodt

Last Updated: June 28, 2022

Gallium ga-68 psma-11 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for gallium ga-68 psma-11 and what is the scope of freedom to operate?

Gallium ga-68 psma-11 is the generic ingredient in one branded drug marketed by Univ Ca Los Angeles and Univ Of Ca San Fran, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for gallium ga-68 psma-11
US Patents:0
Tradenames:1
Applicants:2
NDAs:2
Finished Product Suppliers / Packagers: 1
Clinical Trials: 118
DailyMed Link:gallium ga-68 psma-11 at DailyMed
Recent Clinical Trials for gallium ga-68 psma-11

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidade Federal do ParaN/A
Eli Lilly and CompanyPhase 1/Phase 2
Prostate Cancer FoundationPhase 1/Phase 2

See all gallium ga-68 psma-11 clinical trials

Pharmacology for gallium ga-68 psma-11

US Patents and Regulatory Information for gallium ga-68 psma-11

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Univ Of Ca San Fran GALLIUM GA 68 PSMA-11 gallium ga-68 psma-11 SOLUTION;INTRAVENOUS 212643-001 Dec 1, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Univ Ca Los Angeles GALLIUM GA 68 PSMA-11 gallium ga-68 psma-11 SOLUTION;INTRAVENOUS 212642-001 Dec 1, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Merck
Dow
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.